SAMLYN CAPITAL, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Corvus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (CRVS)

Filing Manager
SAMLYN CAPITAL, LLC
Reporting Manager
SAMLYN CAPITAL, LLC
Security
Corvus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol
CRVS
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 13:32:57 UTC
Date of event
30 Jun 2025
Previous filing
15 May 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SAMLYN CAPITAL, LLC 0% 0 0 0 By: Samlyn, LP, its sole member, By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly Robert Pohly, Managing Member
SAMLYN, LP 0% 0 0 0 By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly Robert Pohly, Managing Member
ROBERT POHLY 0% 0 0 0 By: /s/ Robert Pohly Robert Pohly